Dr. Sherman Featured on NBC Sports

Posted November 17, 2023
Dr. Sherman gave an injury report on Steph Curry’s knee injury on NBC Sports, saying the injury “sounds like more on the minor spectrum”.

You can watch the entire report at https://www.nbcsportsbayarea.com/nba/golden-state-warriors/stanford-doctor-says-currys-knee-injury-sounds-like-more-on-the-minor-spectrum/1672341/?amp=1

Dr. Sherman Featured in Orthopedics Today

Posted May 31, 2022
Video of Dr ShermanOrthopedics Today recently featured a video of Dr. Sherman from the Arthroscopy Association of North America Annual Meeting where he discusses tips and pearls for residents and fellows on maintaining a well-rounded professional and personal lifestyle.

Click here to watch the video

Dr. Sherman on Nailed It: The Orthopedic Surgery Podcast

Posted December 29, 2021

Dr ShermanDr. Sherman recently joined Nailed It: The Orthopedic Surgery Podcast to discuss early knee arthritis, high tibial osteotomy, and knee deformity. You can listen to the full episode at https://naileditortho.com/earlykneeoa/ or on iTunes.

Dr. Sherman Speaks at US FDA Virtual Public Workshop on Cartilage Repair

Posted December 16, 2021
FDA TalkDr. Sherman was honored to be invited by the US FDA to participate in their Virtual Public Workshop on Cartilage Repair. His talk was an evidence based review of focal chondral and osteochondral defects of the knee.

You can watch the talk here: https://fda.yorkcast.com/webcast/Play/578ec34c004c44a89d91c9549f4998031d

Novocart® 3D Research Study

Posted August 18, 2021

Novocart 3DDr. Sherman’s patients who meet eligibility requirements are now able to participate voluntarily in a research study of an investigational biologic/device combination product called Novocart® 3D. This device is being tested for repair of knee cartilage defects.

Novocart® 3D is the cellular implant system that is being investigated in this clinical study. “Investigational” means that this study product has not been approved by the U.S. Food and Drug Administration (FDA) or any regulatory authorities in the United States. The investigational treatment (Novocart® 3D) in this study has been used in Europe since 2003 to treat patients with damaged knee cartilage.

This use of Novocart® 3D involves two separate surgeries. In the first surgery, a small amount of knee cartilage about the size of a pencil eraser is removed from the affected knee and sent to sponsor’s manufacturing facility to be processed for re-implantation. Processing means cleaning and growing your cartilage cells in a sterile container, and then placing your own cells onto a 3-dimentional sponge-like scaffold. These cells are referred to as autologous chondrocytes (autologous = from yourself; chondrocytes = cartilage cells). During a second surgery, approximately three weeks later, the damaged area of your knee cartilage is cleaned and the sponge-like scaffold containing your autologous chondrocytes is implanted into the prepared space of the defect.

The purpose of this research study is to assess the pain, stiffness and physical function of your knee. You will receive one of two possible surgical procedures. One surgical procedure, which is the investigational procedure under study, utilizes the Novocart® 3D autologous cartilage implant system. The other possible procedure is called Microfracture and is one of the current standard of care options to treat your condition. Both surgical procedures will be followed by pain and knee function assessments and a course of physical rehabilitation.

It is possible that you will have significantly improved knee function and reduced pain as a result of these procedures compared to before the surgery. However, this cannot be guaranteed. The KOOS score is an index used to assess pain, and the IKDC score will assess physical function of your knee. Both of these scores include surveys for which you will be asked questions regarding your knee and your daily activities. Additional questionnaires will be given to you such as the SF-36 (short form general health survey), and other questions to assess the impact of your knee injury before and after the study procedures. The results of participants receiving Novocart® 3D will be compared to the results of participants undergoing the Microfracture procedure to see if one of the treatments result in better knee function and less pain.

A description of this clinical trial will be available on http://www.ClinicalTrials.gov as required by U.S. Law. This Web site will not include information that can identify you. At most, the Web site will include a summary of the results. You can search this Web site at any time.

Dr. Sherman Discusses the Evolution of Tibial Tubercle Osteotomy with Orthopedics Today

Posted August 4, 2021

Orthopedics Today VideoDr. Sherman recently discussed the evolution of tibial tubercle osteotomy with Orthopedics Today.

“Anyone who is doing osteotomy at a relatively high volume, I implore you, please, to collect your outcomes, know your indications, follow the patients carefully [and] follow them radiographically,” he said. “Let’s get functional outcomes and return to sport outcomes, and let’s all work to collaborate to continue to push patellofemoral joint preservation well into the future.”

Click here to watch the video.

Dr. Sherman Participating In ICRS Webinar Series

Posted April 27, 2021

Tomorrow I will be participating in a ICRS Webinar Series with orthopedic specialists from Argentina, Italy and the US. Topics covered will include meniscus repair, cell-based cartilage repair, and knee osteotomy.

The event is free and open to all. You can register at http://cartilage.org/webinarseries2021.

Dr. Sherman Featured in ISAKOS Newsletter

Posted April 15, 2021

Dr. Sherman’s article, “ACL Reconstruction 2020: A Worldwide Survey” is featured in the current issue of the ISAKOS newsletter. The article evaluates surgeons’ anterior cruciate ligament reconstruction preferences worldwide.

Click the link below to view/download the PDF. The article begins on page 36.

View/Download PDF

Dr. Sherman Invited Faculty at the Smith+Nephew MACKIS on November 20

Posted November 19, 2020

MACKISDr. Sherman is honored and excited to be invited faculty at the Smith+Nephew MACKIS on Friday, November 20. His sessions will be on patellofemoral and meniscus repair.

Dr. Sherman a Featured Presenter at MACI Regional Surgeon Training

Posted September 20, 2020

MACI RegionalDr. Sherman pleased to join Wayne Gersoff, MD and Geoff Van Thiel, MD as a featured presenter at the MACI Regional Surgeon Training this Monday, September 21. His presentation topic will be “Starting Off on the Right Foot: Assessing MACI Candidates”.

Register for the virtual training at https://form.jotform.com/202153996070152.